Deutsche Bank AG reissued their buy rating on shares of Teleflex Incorporated (NYSE:TFX) in a research report sent to investors on Monday. The brokerage currently has a $251.00 price target on the medical technology company’s stock, up from their previous price target of $238.00.
TFX has been the subject of several other research reports. Leerink Swann upgraded Teleflex from a market perform rating to an outperform rating and lifted their price target for the company from $227.00 to $266.00 in a report on Thursday, September 7th. Zacks Investment Research upgraded Teleflex from a hold rating to a buy rating and set a $223.00 target price for the company in a report on Wednesday, May 24th. Jefferies Group LLC reiterated a buy rating and set a $230.00 target price on shares of Teleflex in a report on Thursday, August 3rd. KeyCorp reiterated a hold rating on shares of Teleflex in a report on Wednesday, September 6th. Finally, BidaskClub cut Teleflex from a buy rating to a hold rating in a report on Monday, July 31st. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have given a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus target price of $259.43.
Teleflex (NYSE:TFX) opened at 237.06 on Monday. Teleflex has a 52-week low of $136.53 and a 52-week high of $240.93. The firm has a market cap of $10.68 billion, a PE ratio of 45.34 and a beta of 1.05. The firm has a 50-day moving average of $216.57 and a 200-day moving average of $205.08.
Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, beating the consensus estimate of $1.91 by $0.13. The company had revenue of $528.60 million during the quarter, compared to analysts’ expectations of $518.98 million. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The firm’s revenue was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.89 EPS. Equities analysts anticipate that Teleflex will post $8.28 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Tuesday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.57%. The ex-dividend date was Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is presently 26.00%.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $211.75, for a total transaction of $42,350.00. Following the transaction, the director now directly owns 8,080 shares of the company’s stock, valued at approximately $1,710,940. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 600 shares of company stock worth $125,652 over the last three months. 2.39% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Toronto Dominion Bank lifted its position in Teleflex by 14.5% during the 2nd quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after acquiring an additional 70 shares in the last quarter. Archford Capital Strategies LLC lifted its position in Teleflex by 29,025.0% during the 2nd quarter. Archford Capital Strategies LLC now owns 1,165 shares of the medical technology company’s stock worth $217,000 after acquiring an additional 1,161 shares in the last quarter. Cookson Peirce & Co. Inc. acquired a new position in Teleflex during the 2nd quarter worth approximately $11,813,000. Advisory Services Network LLC lifted its position in Teleflex by 933.8% during the 2nd quarter. Advisory Services Network LLC now owns 827 shares of the medical technology company’s stock worth $172,000 after acquiring an additional 747 shares in the last quarter. Finally, Koch Industries Inc. lifted its position in Teleflex by 47,174.3% during the 2nd quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after acquiring an additional 957,639 shares in the last quarter. 89.75% of the stock is currently owned by hedge funds and other institutional investors.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with our FREE daily email newsletter.